Literature DB >> 21666065

UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables.

Sandi L Navarro1, Yu Chen, Lin Li, Shuying S Li, Jyh-Lurn Chang, Yvonne Schwarz, Irena B King, John D Potter, Jeannette Bigler, Johanna W Lampe.   

Abstract

Acetaminophen (APAP) glucuronidation is thought to occur mainly by UDP-glucuronosyltransferases (UGT) in the UGT1A family. Interindividual variation in APAP glucuronidation is attributed in part to polymorphisms in UGT1As. However, evidence suggests that UGT2B15 may also be important. We evaluated, in a controlled feeding trial, whether APAP conjugation differed by UGT1A6 and UGT2B15 genotypes and whether supplementation of known dietary inducers of UGT (crucifers, soy, and citrus) modulated APAP glucuronidation compared with a diet devoid of fruits and vegetables (F&V). Healthy adults (n = 66) received 1000 mg of APAP orally on days 7 and 14 of each 2-week feeding period and collected saliva and urine over 12 h. Urinary recovery of the percentage of the APAP dose as free APAP was higher (P = 0.02), and the percentage as APAP glucuronide (APAPG) was lower (P = 0.004) in women. The percentage of APAP was higher among UGT1A6*1/*1 genotypes, relative to *1/*2 and *2/*2 genotypes (P = 0.045). For UGT2B15, the percentage of APAPG decreased (P < 0.0001) and that of APAP sulfate increased (P = 0.002) in an allelic dose-dependent manner across genotypes from *1/*1 to *2/*2. There was a significant diet × UGT2B15 genotype interaction for the APAPG ratio (APAPG/total metabolites × 100) (P = 0.03), with *1/*1 genotypes having an approximately 2-fold higher F&V to basal diet difference in response compared with *1/*2 and *2/*2 genotypes. Salivary APAP maximum concentration (C(max)) was significantly higher in women (P = 0.0003), with F&V (P = 0.003), and among UGT1A6*2/*2 and UGT2B15*1/*2 genotypes (P = 0.02 and 0.002, respectively). APAP half-life was longer in UGT2B15*2/*2 genotypes with F&V (P = 0.009). APAP glucuronidation was significantly influenced by the UGT2B15*2 polymorphism, supporting a role in vivo for UGT2B15 in APAP glucuronidation, whereas the contribution of UGT1A6*2 was modest. Selected F&V known to affect UGT activity led to greater glucuronidation and less sulfation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666065      PMCID: PMC3164274          DOI: 10.1124/dmd.111.039149

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  47 in total

1.  Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers.

Authors:  Jae-Yong Chung; Joo-Youn Cho; Kyung-Sang Yu; Jung-Ryul Kim; Hye-Ryung Jung; Kyoung-Soo Lim; In-Jin Jang; Sang-Goo Shin
Journal:  Clin Pharmacol Ther       Date:  2005-06       Impact factor: 6.875

2.  The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors.

Authors:  Peter I Mackenzie; Dong Gui Hu; Dione A Gardner-Stephen
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

3.  UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial.

Authors:  Jyh-Lurn Chang; Jeannette Bigler; Yvonne Schwarz; Shuying S Li; Lin Li; Irena B King; John D Potter; Johanna W Lampe
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

4.  Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes.

Authors:  Seva E Kostrubsky; Jacqueline F Sinclair; Stephen C Strom; Sheryl Wood; Ellen Urda; Donna Beer Stolz; Yuan H Wen; Shaila Kulkarni; Abdul Mutlib
Journal:  Toxicol Sci       Date:  2005-06-02       Impact factor: 4.849

5.  Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism.

Authors:  Misty R Saracino; Jeannette Bigler; Yvonne Schwarz; Jyh-Lurn Chang; Shiuying Li; Lin Li; Emily White; John D Potter; Johanna W Lampe
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

6.  The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients.

Authors:  A I Sánchez-Fructuoso; M L Maestro; N Calvo; M Viudarreta; I Pérez-Flores; S Veganzone; V De la Orden; D Ortega; M Arroyo; A Barrientos
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

Review 7.  Phytochemical regulation of UDP-glucuronosyltransferases: implications for cancer prevention.

Authors:  Misty R Saracino; Johanna W Lampe
Journal:  Nutr Cancer       Date:  2007       Impact factor: 2.900

Review 8.  Gender differences in pharmacological response.

Authors:  Gail D Anderson
Journal:  Int Rev Neurobiol       Date:  2008       Impact factor: 3.230

9.  Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Shuji Ohno; Shizuo Nakajin
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

10.  Cruciferous vegetable feeding alters UGT1A1 activity: diet- and genotype-dependent changes in serum bilirubin in a controlled feeding trial.

Authors:  Sandi L Navarro; Sabrina Peterson; Chu Chen; Karen W Makar; Yvonne Schwarz; Irena B King; Shuying S Li; Lin Li; Mark Kestin; Johanna W Lampe
Journal:  Cancer Prev Res (Phila)       Date:  2009-03-31
View more
  14 in total

1.  Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.

Authors:  Natacha Lenuzza; Xavier Duval; Grégory Nicolas; Etienne Thévenot; Sylvie Job; Orianne Videau; Céline Narjoz; Marie-Anne Loriot; Philippe Beaune; Laurent Becquemont; France Mentré; Christian Funck-Brentano; Loubna Alavoine; Philippe Arnaud; Marcel Delaforge; Henri Bénech
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-12-03       Impact factor: 2.441

2.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

3.  Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.

Authors:  Michael H Court; Zhaohui Zhu; Gina Masse; Su X Duan; Laura P James; Jerold S Harmatz; David J Greenblatt
Journal:  J Pharmacol Exp Ther       Date:  2017-06-29       Impact factor: 4.030

4.  Inter-individual differences in response to dietary intervention: integrating omics platforms towards personalised dietary recommendations.

Authors:  Johanna W Lampe; Sandi L Navarro; Meredith A J Hullar; Ali Shojaie
Journal:  Proc Nutr Soc       Date:  2013-02-06       Impact factor: 6.297

Review 5.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

6.  The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C>G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure.

Authors:  Michael H Court; Marina Freytsis; Xueding Wang; Inga Peter; Chantal Guillemette; Suwagmani Hazarika; Su X Duan; David J Greenblatt; William M Lee
Journal:  J Pharmacol Exp Ther       Date:  2013-02-13       Impact factor: 4.030

Review 7.  Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Pharm Res       Date:  2013-03-06       Impact factor: 4.200

8.  Soybean greatly reduces valproic acid plasma concentrations: a food-drug interaction study.

Authors:  Anu Marahatta; Bidur Bhandary; Seul-Ki Jeong; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Sci Rep       Date:  2014-03-12       Impact factor: 4.379

9.  The Genomics of Elevated ALT and Adducts in Therapeutic Acetaminophen Treatment: a Pilot Study.

Authors:  Andrew A Monte; Brandon Sonn; Jessica Saben; Barry H Rumack; Kate M Reynolds; Richard C Dart; Kennon J Heard
Journal:  J Med Toxicol       Date:  2020-10-13

10.  Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children.

Authors:  X-L Jiang; P Zhao; J S Barrett; L J Lesko; S Schmidt
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.